PREVALENCE OF TRANSTHYRETIN CARDIAC AMYLOIDOSIS IN PATIENTS HOSPITALIZED FOR HEART FAILURE

被引：0
|
作者：
Lanati, G.
Aschieri, D.
Di Dio, M.
Calabro, D.
Mori, M.
Piepoli, M.
Rusticali, G.
机构：
[1] UOSD Cardiol & Riabilitaz Cardiol, Castelsangiovanni, Italy
[2] UOC Cardiol & UTIC, Piacenza, Italy
[3] UO Med Nucl, Piacenza, Italy
[4] Policlin San Donato, Milan, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P208
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prevalence of transthyretin cardiac amyloidosis in patients hospitalized for heart failure with preserved ejection fraction and septal thickness.
    Decotto, Santiago
    Villar, Gonzalo Fernandez
    Llamedo, Maria Clara
    Villanueva, Eugenia
    De Arenaza, Diego Perez
    Lucas, Luciano
    Del Castillo, Santiago
    Rossi, Emiliano
    Belziti, Cesar
    Pizarro, Rodolfo
    MEDICINA-BUENOS AIRES, 2024, 84 (05) : 823 - 830
  • [2] High prevalence of heart failure with reduced ejection fraction in patients with transthyretin cardiac amyloidosis
    Talal Asif
    Tiago Araujo
    Vasvi Singh
    Saurabh Malhotra
    Journal of Nuclear Cardiology, 2020, 27 : 1044 - 1046
  • [3] High prevalence of heart failure with reduced ejection fraction in patients with transthyretin cardiac amyloidosis
    Asif, Talal
    Araujo, Tiago
    Singh, Vasvi
    Malhotra, Saurabh
    JOURNAL OF NUCLEAR CARDIOLOGY, 2020, 27 (03) : 1044 - 1046
  • [4] HIGH PREVALENCE OF HEART FAILURE WITH REDUCED EJECTION FRACTION AMONG PATIENTS WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS
    Asif, Talal
    Araujo, Tiago
    Singh, Vasvi
    Alyousef, Tareq
    Valencia, Javier Gomez
    Doukky, Rami
    Malhotra, Saurabh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1728 - 1728
  • [5] Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction
    Healy, L.
    Giblin, G.
    Gray, A.
    Starr, N.
    Murphy, L.
    O'Sullivan, D.
    Kavanagh, E.
    Howley, C.
    Tracey, C.
    Morrin, E.
    Mcdaid, A.
    Clarke, A.
    O'Neill, J. O.
    Joyce, E.
    O'Connell, M.
    Mahon, N. G.
    ESC HEART FAILURE, 2025, 12 (02): : 1176 - 1182
  • [6] Prevalence of transthyretin cardiac amyloidosis in a community-based heart failure population
    Lindmark, K.
    Pilebro, B.
    Solekrans, L.
    Wixner, J.
    Anan, I.
    Suhr, O.
    Lindqvist, P.
    EUROPEAN HEART JOURNAL, 2019, 40 : 132 - 132
  • [7] The prevalence of transthyretin amyloidosis in patients with heart failure with preserved ejection fraction
    Oh, J. Jaewon
    Kim, S. E.
    Lee, S.
    Lee, C. J.
    Kang, S. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 359 - 359
  • [8] Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy
    Devesa, Ana
    Camblor Blasco, Andrea
    Pello Lazaro, Ana Maria
    Askari, Elham
    Lapena, Gregoria
    Gomez Talavera, Sandra
    Taibo Urquia, Mikel
    Rodriguez Olleros, Celia
    Tunon, Jose
    Ibanez, Borja
    Acena, Alvaro
    ESC HEART FAILURE, 2021, 8 (04): : 2856 - 2865
  • [9] Prevalence of transthyretin amyloidosis in patients with heart failure with preserved ejection fraction
    Naito, T.
    Nakamura, K.
    Abe, Y.
    Sakuragi, S.
    Kihara, H.
    Okizaki, A.
    Kawai, Y.
    Watanabe, H.
    Yoshikawa, M.
    Takaishi, A.
    Fujio, H.
    Otsuka, H.
    Ogura, S.
    Nomura, N.
    Ito, H.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1079 - 1079
  • [10] Impact of cardiac amyloidosis on outcomes of patients hospitalized with heart failure
    Gobel, Sebastian
    Hobohm, Lukas
    Desuki, Alexander
    Gori, Tommaso
    Muenzel, Thomas
    Claudio, Rapezzi
    Wenzel, Philip
    Keller, Karsten
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 102 : 88 - 96
12345